I mostly agree with this list but, out of the items listed that CYDY actually has direct control over, I'd say "completing enrollment in mild/moderate" is the most vital. Right now I don't see any larger obstacle to our FDA approval than completing a trial to show "the data".

Last week was
Manufacturing, Manufacturing , Manufacturing

Now it's
Enrollment, Enrollment, Enrollment